We are pleased to invite investors and analysts to participate in a live webinar on Wednesday, 17 November 2021, highlighting Roche's development in digital technology, data and advanced analytics. 16:00 - 17:30 CET / 15:00 - 16:30 GMT 10:00 - 11:30 am EST / 07:00 - 08:30 am PST The webinar will be hosted by Alan Hippe, Chief Financial and IT Officer, and other senior leaders in the space followed by a Q&A session. The event will outline the overall strategy and highlight >20 use cases (including launched products) from the pharmaceuticals & diagnostics divisions. Use cases presented will cover the entire traditional value chain (early R&D, clinical development, regulatory & reimbursement, manufacturing, commercialization, diagnosis) as well as novel treatment/decision support solutions for physicians and patients. Presenters include:
The slides will be available for download at 15:00 CET on the day of the event. > click here We would like to invite all interested parties to participate in the webinar and to pre-register here.* Should you be unable to register for the webinar due to your company IT policy, please send an email to investor.relations@roche.com. A replay of the webcast will be available via >ir.roche.com *privacy notice | ||
Best regards, Karl Mahler Head of Investor Relations | Bruno Eschli Investor Relations Officer | Gerard Tobin Investor Relations Officer |
Roche Investor Relations | ||
Dr. Karl Mahler Phone: +41 61 68-78503 e-mail: karl.mahler@roche.com |
Jon Kaspar Bayard Phone: +41 61 68-83894 e-mail: jon_kaspar.bayard@roche.com | |
Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com |
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com | |
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com |
Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com | |
Investor Relations North America | ||
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com |
Attachments
- Original document
- Permalink
Disclaimer
Roche Holding AG published this content on 11 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 November 2021 13:06:02 UTC.